188 related articles for article (PubMed ID: 14722295)
1. The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection.
Smith JG; Mothes W; Blacklow SC; Cunningham JM
J Virol; 2004 Feb; 78(3):1403-10. PubMed ID: 14722295
[TBL] [Abstract][Full Text] [Related]
2. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
Delos SE; Godby JA; White JM
J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
[TBL] [Abstract][Full Text] [Related]
3. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein.
Mothes W; Boerger AL; Narayan S; Cunningham JM; Young JA
Cell; 2000 Nov; 103(4):679-89. PubMed ID: 11106737
[TBL] [Abstract][Full Text] [Related]
4. Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.
Holmen SL; Melder DC; Federspiel MJ
J Virol; 2001 Jan; 75(2):726-37. PubMed ID: 11134286
[TBL] [Abstract][Full Text] [Related]
5. Receptor-induced thiolate couples Env activation to retrovirus fusion and infection.
Smith JG; Cunningham JM
PLoS Pathog; 2007 Dec; 3(12):e198. PubMed ID: 18260686
[TBL] [Abstract][Full Text] [Related]
6. Residues 28 to 39 of the Extracellular Loop 1 of Chicken Na
Guan X; Zhang Y; Yu M; Ren C; Gao Y; Yun B; Liu Y; Wang Y; Qi X; Liu C; Cui H; Zhang Y; Gao L; Li K; Pan Q; Zhang B; Wang X; Gao Y
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070685
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary pressure of a receptor competitor selects different subgroup a avian leukosis virus escape variants with altered receptor interactions.
Melder DC; Pankratz VS; Federspiel MJ
J Virol; 2003 Oct; 77(19):10504-14. PubMed ID: 12970435
[TBL] [Abstract][Full Text] [Related]
8. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
9. A genetically engineered cell line resistant to subgroup J avian leukosis virus infection (C/J).
Hunt HD; Lee LF; Foster D; Silva RF; Fadly AM
Virology; 1999 Nov; 264(1):205-10. PubMed ID: 10544146
[TBL] [Abstract][Full Text] [Related]
10. Alpharetrovirus envelope-receptor interactions.
Barnard RJ; Young JA
Curr Top Microbiol Immunol; 2003; 281():107-36. PubMed ID: 12932076
[TBL] [Abstract][Full Text] [Related]
11. Molecular and biological characterization of a naturally occurring recombinant subgroup B avian leukosis virus with a subgroup J-like long terminal repeat.
Lupiani B; Pandiri AR; Mays J; Hunt HD; Fadly AM
Avian Dis; 2006 Dec; 50(4):572-8. PubMed ID: 17274296
[TBL] [Abstract][Full Text] [Related]
12. Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein.
Hernandez LD; Peters RJ; Delos SE; Young JA; Agard DA; White JM
J Cell Biol; 1997 Dec; 139(6):1455-64. PubMed ID: 9396751
[TBL] [Abstract][Full Text] [Related]
13. Na+/H+ exchanger type 1 is a receptor for pathogenic subgroup J avian leukosis virus.
Chai N; Bates P
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5531-6. PubMed ID: 16567631
[TBL] [Abstract][Full Text] [Related]
14. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
Melikyan GB; Barnard RJ; Markosyan RM; Young JA; Cohen FS
J Virol; 2004 Apr; 78(7):3753-62. PubMed ID: 15016895
[TBL] [Abstract][Full Text] [Related]
15. A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation.
Chen J; Wharton SA; Weissenhorn W; Calder LJ; Hughson FM; Skehel JJ; Wiley DC
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12205-9. PubMed ID: 8618870
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of monoclonal antibodies to subgroup A avian leukosis virus.
Qiu Y; Li X; Fu L; Cui Z; Li W; Wu Z; Sun S
Vet Comp Oncol; 2014 Mar; 12(1):47-51. PubMed ID: 23615298
[TBL] [Abstract][Full Text] [Related]
17. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth.
Melikyan GB; Barnard RJ; Abrahamyan LG; Mothes W; Young JA
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8728-33. PubMed ID: 15937118
[TBL] [Abstract][Full Text] [Related]
18. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
19. An NF-kappa B-dependent survival pathway protects against cell death induced by TVB receptors for avian leukosis viruses.
Chi Y; Diaz-Griffero F; Wang C; Young JA; Brojatsch J
J Virol; 2002 Jun; 76(11):5581-7. PubMed ID: 11991986
[TBL] [Abstract][Full Text] [Related]
20. Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry.
Kvaratskhelia M; Clark PK; Hess S; Melder DC; Federspiel MJ; Hughes SH
Virology; 2004 Aug; 326(1):171-81. PubMed ID: 15262505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
